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Abstract
Strokectomy means surgical excision of infarcted brain tissue post-stroke with preservation of skull integrity, distinguishing 
it from decompressive hemicraniectomy. Both can mitigate malignant middle cerebral artery (MCA) syndrome but evidence 
regarding strokectomy is sparse. Here, we report our data and meta-analysis of strokectomy compared to hemicraniectomy for 
malignant MCA infarction. All malignant MCA stroke cases requiring surgical intervention in a large tertiary centre (Janu-
ary 2012–December 2017, N = 24) were analysed for craniotomy diameter, complications, length of follow-up and outcome 
measured using the modified Rankin score (mRS). Good outcome was defined as mRS 0–3 at 12 months. In a meta-analysis, 
outcome from strokectomy (pooled from our cohort and published strokectomy studies) was compared with hemicraniectomy 
(our cohort pooled with published DECIMAL, DESTINY and HAMLET clinical trial data). In our series (N = 24, 12/12 
F/M; mean age: 45.83 ± 8.91, range 29–63 years), 4 patients underwent strokectomy (SC) and 20 hemicraniectomy (HC). 
Among SC patients, craniotomy diameter was smaller, relative to HC patients (86 ± 13.10 mm, 120 ± 4.10 mm, respectively; 
p = 0.003), complications were less common (25%, 55%) and poor outcomes were less common (25%, 70%). In the pooled 
data (N = 41 SC, 71 HC), strokectomy tended towards good outcome more than hemicraniectomy (OR 2.2, 95% CI 0.99–4.7; 
p = 0.051). In conclusion, strokectomy may be non-inferior, lower risk and cost saving relative to hemicraniectomy sufficiently 
to be worthy of further investigation and maybe a randomised trial.
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Introduction
Malignant middle cerebral artery (MCA) infarction is a life-
threatening medical emergency that carries a poor prognosis 
with mortality of up to 80% in untreated patients [10, 15]. 
In malignant MCA syndrome expanding oedema causes 
mass effect, a substantial rise in intracranial pressure (ICP) 
and reduction of cerebral blood flow (CBF) [11]. Malignant 
MCA syndrome can cause further infarction in other vas-
cular territories especially the anterior cerebral artery [15]. 
Medical treatment alone to reduce the raised intracranial 
pressure is not effective [10, 14, 15].
Decompressive hemicraniectomy (hemicraniectomy) sig-
nificantly reduces mortality and improves functional out-
come following malignant MCA infarction [4]. The initial 
three randomised controlled trials (DECIMAL [40], HAM-
LET [13] and DESTINY [18]) considered individually or 
with pooled patient data analysis demonstrated that hemi-
craniectomy was superior to medical management alone in 
both survival and functional outcome measured using the 
modified Rankin score (mRS) where good outcome was 
defined as mRS ≤ 3 [13, 18, 39, 40]. The objective with 
hemicraniectomy is to avoid secondary brain damage from 
elevated ICP and herniation. Hemicraniectomy survivors 
must undergo a second surgical procedure to close the skull 
defect (cranioplasty). This procedure carries risks from 
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evolving brain injury while awaiting cranioplasty and also 
from potential complications of the procedure itself, which 
include infection and air embolism [33]. Hemicraniectomy 
can also cause a syndrome of the trephined [1] or hydro-
cephalus [27]. Therefore, hemicraniectomy while improving 
survival and outcome also comes with significant risk and 
additional cost.
Partial resection of infarcted frontal and/or temporal lobe 
with preservation of skull integrity, termed “strokectomy”, 
has been suggested either as an adjuvant or surgical alterna-
tive to hemicraniectomy to effect decompression [23, 35, 
38]. Surgical decompression (including strokectomy) for 
cerebellar infarction is well established and associated with 
improved outcome [16, 19, 29, 37]. Whether supratentorial 
or infratentorial, the rationale of strokectomy is to resect 
just enough infarcted brain tissue to alleviate the deleterious 
effects of progressive cerebral oedema, allowing the bone 
flap to be replaced immediately. This precludes the need 
for cranioplasty and its associated complications [9, 33]. In 
addition, removal of the anterior temporal lobe may rapidly 
relieve brainstem compression. The main risk is that resec-
tion of infarcted brain may not be sufficient to contain the 
oedema, and the decompression could be overwhelmed by 
further swelling.
In this study, we present a small case series of patients 
with malignant MCA infarction who underwent either 
strokectomy or hemicraniectomy as a primary procedure. 
We also performed a meta-analysis of our data combined 
with published outcome data from other strokectomy reports 
and three hemicraniectomy randomised trials (DECIMAL, 
DESTINY, HAMLET).
Methods
This retrospective cohort study was registered as an audit 
with our institutional approval (AUDI000525). A data-
base was created for all malignant MCA stroke cases 
requiring surgical intervention during the period from 
January 2012 to December 2017 inclusive. Data were 
analysed for patients’ age, sex, comorbidities, neurologi-
cal status (GCS), side of the stroke, size of craniotomy, 
complications, length of follow-up and outcome meas-
ured using the modified Rankin score (mRS). Computed 
tomography (CT) scan of the head was the imaging used 
for diagnosis of MCA stroke. Patients received medical 
therapy that included oxygen, diuretics, mannitol and/
or hypertonic saline infusion as appropriate on the ward 
but still deteriorated in terms of drop in conscious level 
(stop obeying commands). Surgery was indicated subject 
to clinical and imaging evaluation by experienced neu-
rosurgeons. Midline shift of > 5 mm; involvement of 2/3 
of the MCA territory; signs of trans-tentorial herniation 
or progressive worsening of neurological status indicated 
emergency decompression. The stroke and neurosurgery 
teams discussed each case thoroughly before proceeding 
to surgery. The surgical procedure including the technique 
was discussed with the patient (if appropriate) or next of 
kin before proceeding in the patient’s best interests.
Surgical procedure
In our institution, the main surgical procedure for malig-
nant MCA stroke is hemicraniectomy. However, we also do 
strokectomy for cerebellar infarcts and Mr P Minhas intro-
duced strokectomy as a potential one-off definitive proce-
dure for malignant MCA infarction. Whenever Mr P Minhas 
receives a referral of malignant MCA infarction, he reviews 
all CT scans of the patient and considers whether stroke-
ctomy maybe a simpler alternative. It is then performed 
by his surgical team under close supervision. All patients 
with malignant middle cerebral artery syndrome who were 
referred during Mr Minhas’s on call and required surgical 
treatment went for strokectomy. After the consent procedure, 
emergency anaesthetic preparation included transfusion of 
1–2 pools of platelets to patients on high dose or dual anti-
platelet therapy. At least one pool of platelets was given prior 
to surgery. Mannitol and hypertonic saline were considered 
on a case-by-case basis. Surgically, a curved temporal inci-
sion was made anterior to the tragus followed by a small 
standard craniotomy tailored to the ischaemic brain tissue 
area. The dura was opened in a C-shape and reflected. The 
ischaemic tissue was identified as non-viable blanched brain 
tissue, soft, grey, swollen with no evidence of perfusion. 
Subpial resection was performed with assistance of suction 
and bipolar forceps. Infarcted brain undergoes liquefactive 
necrosis and, hence, is possible to use gentle suction and 
irrigation to resect infarcted tissue without disturbing viable 
brain. Sufficient ischaemic brain tissue was resected to opti-
mise a manageable frontal and/or temporal lobe and be able 
to replace the bone flap. The dura was left open and the bone 
flap was replaced free riding with attached plates to maintain 
convexity integrity. Patients were admitted to intensive care 
following surgery. CT head was performed within 48 h of 
surgery or as clinically needed. Antithrombotic therapy was 
re-started after reviewing the CT as necessary. Figure 1 dem-
onstrates malignant left MCA and PCA territory infarction 
in a 36-year-old male who deteriorated following admission 
and had surgery at 46 h from the onset of stroke.
The pre-operative plan was to perform strokectomy and 
hemicraniectomy was not an option. We are not aware of 
any selection bias as strokectomy is the strategy of Mr 
Minhas practise, and all patients referred during his on 
call had this procedure (Fig. 2).
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Fig. 1  A 36-year-old male with malignant L MCA stroke. a Preopera-
tive axial CT scan demonstrating severe midline shift. b 48-h postop-
erative axial CT scan with debulking of ischemic tissue from the left 
temporal lobe, there is evident midline shift despite clinical improve-
ment in neurological status. c An axial CT head of the same patient 
at 1 month following surgery. d This is a skull scout image, showing 
the craniotomy size, the free riding mini-plates attached to the crani-
otomy flap only and that the bone did not sink into the cranial vault 
3 years post-surgery. This patient recovered to mRS 2
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Outcome
Outcome was measured using the mRS by independent 
clinicians immediately preoperatively and 12  months 
post-operatively. Patients, their next of kin or carers were 
contacted for a 12-month mRS if they did not attend in 
person. Outcome was dichotomised into ‘good’ if mRS ≤ 3 
or ‘poor’ if mRS ≥ 4.
Search strategy for systematic review
An extensive literature search was performed includ-
ing PubMed, Google Scholar, OVID, EMBASE and the 
Cochrane Central Register of Controlled Trials (CEN-
TRAL). Limits were placed on all articles to those pub-
lished between 1990 and 2019 inclusive and written 
in English only. Search terms were charted to subject 
Records idenfied through 
database searching
Google Scholar (n = 42)
OVID MEDLINE, EMBASE (n = 79)
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Fig. 2  PRISMA flow diagram of Google scholar, PubMed, Ovid, Medline, Embase and Cochrane until December 2019
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headings and combined using Boolean operations. The fol-
lowing keywords were used for search: “natural history”, 
“malignant infarction”, “supratentorial infarction”, “risk 
factors”, “survival rates”, “decompressive craniectomy”, 
“strokectomy”, “infarcted tissue removal”, “medical ther-
apy”. Abstracts of papers found in the literature search 
were scrutinised independently by two authors (SM and 
AS) to assess suitability for inclusion. Reference lists from 
the papers identified in the literature search were manually 
searched to ascertain other articles suitable for inclusion. 
Inclusion criteria were: any article that described malig-
nant MCA infarction patients who underwent infarcted 
brain tissue resection either as a primary procedure or 
secondary surgery following hemicraniectomy. Primary 
procedure was when strokectomy was the intended opera-
tion, while secondary procedure was when a resection of 
infarcted brain tissue was performed in addition to hemi-
craniectomy in the same setting or at a later operation to 
reduce ICP. In the meta-analysis, we included all articles 
that strokectomy was performed as primary surgical proce-
dure in the treatment of malignant MCA infarction. Those 
with no outcome or when strokectomy was performed as 
secondary procedure were excluded.
The systematic review and meta-analysis were per-
formed following PRISMA guidelines.
Statistical analysis
For our cohort data analysis: continuous numeric vari-
ables are summarised as mean and standard error of the 
mean. The differences in the numeric variables of the two 
groups were evaluated with a Mann–Whitney U test for 
non-parametric statistical analysis. Chi-square with Fish-
er’s exact test was employed to compare categorical data 
between the groups. Statistical significance was consid-
ered if p < 0.05. Statistical analyses were performed using 
GraphPad Prism version 8.02 for Windows 10, GraphPad 
Software, La Jolla, CA, USA.
For the systematic review, strokectomy data were ana-
lysed using patient outcomes from our data pooled with data 
from three strokectomy studies [20, 22, 38] and compared 
to pooled hemicraniectomy data taken from our data and 
the hemicraniectomy studies “DECIMAL, DESTINY and 
HAMLET” [39]. In total, the pooled dataset consisted of 
41 patients in the strokectomy group and 71 patients in the 
hemicraniectomy group. A good outcome was defined as 
mRS 0–3 with poor outcome separated into mRS 4 and 5 
or death (mRS 6) at 12 months. Absolute risk reduction 
(ARR), odds ratio (OR) and 95% confidence intervals were 
calculated for our data and pooled data where possible. Chi-
squared was used for the pooled dataset and Fisher’s Exact 
test for our dataset to compare the two interventions.
Results
Patients’ characteristics from the present cohort are sum-
marised in Table 1. Four hemicraniectomy patients had 
ICA, ACA and PCA territory infarction, while two of the 
strokectomy patients had additional ACA and ICA terri-
tory infarcts. No patients presented with pupillary abnor-
mality or cardiovascular instability before surgery. There 
was no significant difference between the two groups 
in any of the listed clinical demographics, pre-surgery 
GCS or mRS. In the hemicraniectomy group, none of the 
patients had secondary strokectomy (or temporal lobec-
tomy). Likewise, none of the strokectomy group patients 
had secondary hemicraniectomy.
Craniotomy diameter in hemicraniectomy 
versus strokectomy
The average craniotomy diameter was significantly smaller 
in the strokectomy compared to the hemicraniectomy 
cohorts (85 ± 4.1 mm vs. 120 ± 13.1 mm; p = 0.003).
Patients’ outcome
The average in-person clinic follow-up for both groups 
was 14 months (range 3–36). Those who did not have a 
12-month clinic review were contacted and their mRS was 
recorded. Median mRS at 12 months was 3 (range 2–4) 
for strokectomy and 4 (range 1–6) for hemicraniectomy 
(p = 0.08). Mortality at one year was zero (0/4) in the 
strokectomy group and 35% (7/20) in the hemicraniectomy 
group. A good outcome (mRS ≤ 3) was observed in 75% 
(3/4) and 30% (6/20) of patients in the strokectomy and 
hemicraniectomy cohorts, respectively (Fig. 3) (Tables 2 
and 3).
Complications
In the strokectomy group, 1 patient (25%) developed pneu-
mocephalus and then recovered with outcome mRS = 4. In 
the hemicraniectomy group, four patients (20%) developed 
seizures (2 shortly after the surgery and two following 
cranioplasty). All 4 had poor neurological status on admis-
sion and poor outcomes. A further four patients (20%) in 
this group developed pneumonia which was treated suc-
cessfully with antibiotics. One patient developed hydro-
cephalus and another patient developed atrial fibrillation.
Six patients out of the 13 who survived in the hemi-
craniectomy group underwent cranioplasty where two 
developed seizures. The remaining seven patients required 
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nursing home care and were fully dependent; they were 
considered unsuitable for cranioplasty.
Systematic review and meta‑analysis
Among 122 retrieved studies, 114 were excluded because 
of duplicates or because titles and abstracts did not meet 
the inclusion criteria (Fig. 2). In the remaining eight, full 
texts were assessed for eligibility and 5 were excluded 
because they did not include strokectomy as a primary 
procedure for the treatment of malignant MCA infarction 
[5, 23–25, 35]. We included three studies [20, 22, 38] 
with a total of 37 patients. Overall, the SC dataset com-
prised four studies (including ours) for outcome analysis 
(pooled N = 41) [20, 22, 38]. For the HC analysis, we 
pooled data from DECIMAL [40], DESTINY [18] and 
HAMLET [39]” studies with our data (pooled N = 71 
patients). Both in our data and in the pooled data, there 
was a trend for better outcomes for strokectomy than for 
hemicraniectomy (for mRS ≤ 3, our data: OR 7.0, 95% CI 
0.6—81, pooled data: OR 2.2, 95% CI 0.99–4.7; Fig. 3a 
and b).
Table 1  Baseline 
demographics and clinical 
data of hemicraniectomy and 
strokectomy of local department 
cohorts
rtPA: recombinant tissue plasminogen activator. mRS: Modified Rankin score. NIHSS: National Institutes 
of Health Stroke Scale. Age and time “stroke-to-surgery” are expressed as mean ± standard error of the 
mean. NIHSS, GCS and mRS are expressed as median. *p < 0.05 is significant. **Mann–Witney test was 
used in this analysis
Hemicraniectomy Strokectomy p value
N 20 4 –
Male 9 3 0.59
Female 11 1
Age 44.7 ± 1.8 51.5 ± 5.97 0.19
Side 7 left, 13 right 2 left, 2 right 0.61
Treatment with rtPA 12 3 0.30
Thrombectomy 3 0 –
Stroke type 13 3 –
 Atherothrombotic 6 0 –
 Cardio-embolic Carotid dissection (n = 1) Carotid dissection (n = 1) –
 Other
Infarction territory 20 MCA, additionally 1 ICA, 
2 ACA and 1 PCA
4 MCA, additionally 1 ICA 
and 1 ACA 
–
NIHSS (on admission) 15 (range 6–24) 21.5 (range 17–25) 0.06
NIHSS (pre-operative) 21 (range 10–35) 28 (range 23–31) 0.04*
GCS (pre-operative) 9 (range 6–13) 8 (range 3–12) 0.30
mRS (on admission) 5 (range 3–5) 5 (range 4–5) 0.87
mRS (at follow-up) 4 (range 1–6) 3 (range 2–4) 0.08**
Time between stroke and surgery 33.0 ± 2.8 h (range 12–60) 41.3 ± 5.8 h (range 24–48) 0.30
Table 2  Studies that included 
malignant MCA infarction 
patients who underwent 
strokectomy or resection of 
infarcted brain tissue either 
as a primary surgery or as an 
adjuvant secondary procedure
Y = Yes, N = No
Article Primary or secondary 
strokectomy







Kalia et al. (1993) Primary 4 Y Y
Cho et al. (2003) Secondary 13 Y N
Kostov et al. (2012) Primary 18 Y Y
Lee et al. (2013) Secondary 26 Y N
Merenda et al. (2015) Secondary 3 Y N
Kürten et al. (2018) Secondary 20 Y N
Schwake et al. (2019) Secondary 12 Y N
Tartara et al. 2019 Primary 15 Y Y
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Discussion
The main finding in our report is that from the available 
evidence, strokectomy may have a role in the surgical man-
agement of supratentorial malignant stroke syndromes. It 
may provide a simpler operative procedure with potentially 
fewer complications and avoid the cost and complications 
of a secondary cranioplasty procedure. It appears to be 
of sufficient promise for further investigation and maybe 
a trial versus decompressive hemicraniectomy to better 
evaluate the risks, benefits and comparative merits of the 
two surgical strategies.
Hemicraniectomy is superior to standard medical ther-
apy (without surgery) and greatly improves the survival 
and functional outcome of patients with malignant MCA 
infarction. [7, 39] However, hemicraniectomy as a sur-
gical procedure has inherent complications that include 
infection, haemorrhage, CSF disturbance and seizures. [2, 
3, 6, 19, 26, 34] Hydrocephalus is reported prior to and 
following hemicraniectomy, and is associated with signifi-
cant morbidity. [32, 34, 36] Syndrome of the trephined is 
another complication that has been described and arises 
from the loss of skull integrity from leaving the bone flap 
out. It is characterised by cognitive and neurological dis-
turbance but normally improves following cranioplasty. 
[1] Hemicraniectomy usually entails a second operation, 
cranioplasty, performed several months later. Cranioplasty 
brings additional costs, in the range of $25,000–29,000 
[8] and there is controversy surrounding timing, bone flap 
preservation and complications that include infection, sei-
zures, hydrocephalus, further neurological damage and 
death. [6, 9, 17, 30, 33] There is also a theoretical concern 
that herniated brain after hemicraniectomy has impaired 
venous return which leads to further infarction [12, 28, 41] 
which can be avoided in strokectomy. Our analyses show a 
clear trend towards improved outcome in the strokectomy 
group when compared to hemicraniectomy.
Strokectomy has been widely adopted in the treat-
ment of cerebellar ischaemic infarcts. [21, 29, 31, 37] 
Some elements of strokectomy are already used such as 
supratentorial resection of infarcted brain tissue includ-
ing the temporal pole as an adjuvant procedure following 
hemicraniectomy either to control ICP intraoperatively or 
when there is a refractory rise in ICP. [20, 23–25, 35] 
Strokectomy as a primary surgical procedure where the 
bone flap is replaced has been described in small series. 
[20, 22, 38] Our technique is slightly different and craniot-
omies in our strokectomy group were significantly smaller 
when compared to those who underwent hemicraniectomy. 
Likewise, Tartara et al. independently reported smaller 
craniotomies in strokectomy cases. [38] In our cohort, we 
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were minimal after the procedure and none of the patients 
had post-surgery haemorrhage. Haemostasis was satisfac-
tory during surgery with no bleeding encountered in the 
subpial resection of the dead tissue and the surgery was 
straightforward. Although we were prepared to do second-
ary craniectomy for the strokectomy patients, none in our 
cohort needed that. Our cohort is small and data should 
interpreted with caution; larger studies are needed.
Our literature review identified that supratentorial stroke-
ctomy procedure was being carried out in some centres 
either as a primary operation or a secondary procedure for a 
refractory rise in ICP. [5, 20, 22–25, 35, 38] Our local data 
concur with the published literature which suggests strokec-
tomy is safe, and may be not be inferior to hemicraniectomy, 
in the management of malignant MCA infarction. Pooling 
the outcome results of four studies that included strokectomy 
as a primary procedure, we report survival of 88% and good 
outcome in 59%. There may be a trend towards significantly 
improved outcome. The hemicraniectomy data from Vahedi 
et al. included patients with NIHSS > 15, those between 18 
and 60 years old and operation performed within 45 h of 
stroke; these may not accurately match the data from the 
strokectomy group. This comes as one of the limitations of 
this retrospective analysis and should be taken into consid-
eration in future studies.
Limitations
Our retrospective, local study of strokectomy patients was 
too small for definitive conclusions to be drawn. Such a 
small series may also be prone to selection bias, although, 
we are not aware of a systematic bias in selecting these 
patients. Given that the metanalysis was not a randomised 
(nor systematically selected) sample, it is likely the base-
line characteristics in the two groups may not be balanced. 
However, while our study was small, the data are robust to 
be considered as hypothesis generating.
Conclusion
Our study suggests that strokectomy can be used safely to 
manage malignant middle cerebral artery syndrome and has 
some prospective advantages over hemicraniectomy, such as 
the avoidance of bone reconstruction and its sequelae. These 
findings support further evaluation of the safety and efficacy 
of this approach and potentially a clinical trial.
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